| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.7 |